Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy Authors: Mari Iida, Toni M. Brand, Megan M. Starr, Evan J. Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler Published: 2025 Correction : Mol Cancer 13, 242 (2014) https://doi.org/10.1186/1476-4598-13-242 Following publication of the original article [1], Figure 1A contained incorrect blots. Specifically, the blots for pEGFR, EGFR, pMAPK, MAPK, and α-tubulin were inadvertently sourced from a previous publication. After working closely with the editorial team, the authors have now provided the correct blots for Figure 1A. This correction does not impact the findings or conclusions of the article. The authors sincerely regret any inconvenience this may have caused and appreciate the opportunity to make this correction. The correct Fig. 1 is shown below.Fig. 1Cetuximab-resistant (CtxR ) clones have increased HER family receptor activity. (A) CtxR cells have increased HER family activity as well as phosphorylation levels of downstream signaling molecules. Parental (HP) and CtxR clones (HC1, HC4, HC8) were harvested and protein lysates were fractionated on SDS-PAGE followed by Immunoblotting for the indicated proteins. α-Tubulin was used as a loading control. (B) Expression of EGFR and HER3 on the plasma membrane is increased in CtxR clones compared to cetuximab-sensitive (CtxS) cells (HP). The levels of EGFR and HER3 on the cell surface were measured by flow cytometry. (n = 3) (C) EGFR displayed increased association with HER3 in all three CtxR clones compared to CtxS HP cell line. Cells were harvested and EGFR or HER3 were immunoprecipitated with anti-rabbit EGFR antibody or anti-rabbit HER3 antibody. The immunoprecipitate complexes were fractionated on SDS-PAGE followed by immunoblotting for indicated proteins Cetuximab-resistant (CtxR ) clones have increased HER family receptor activity. (A) CtxR cells have increased HER family activity as well as phosphorylation levels of downstream signaling molecules. Parental (HP) and CtxR clones (HC1, HC4, HC8) were harvested and protein lysates were fractionated on SDS-PAGE followed by Immunoblotting for the indicated proteins. α-Tubulin was used as a loading control. (B) Expression of EGFR and HER3 on the plasma membrane is increased in CtxR clones compared to cetuximab-sensitive (CtxS) cells (HP). The levels of EGFR and HER3 on the cell surface were measured by flow cytometry. (n = 3) (C) EGFR displayed increased association with HER3 in all three CtxR clones compared to CtxS HP cell line. Cells were harvested and EGFR or HER3 were immunoprecipitated with anti-rabbit EGFR antibody or anti-rabbit HER3 antibody. The immunoprecipitate complexes were fractionated on SDS-PAGE followed by immunoblotting for indicated proteins